The fungus, Candida auris is an emerging
“superbug” and is fast becoming a global health threat.
The CDC has added drug-resistant C. auris to a list of
germs, which are considered as “urgent threats.”
C. auris has
been reported from South Korea, India, Pakistan, Kuwait, Israel, Oman, South
Africa, Colombia, Venezuela, the United States, Canada, and Europe, including
the United Kingdom, Norway, Germany and Spain (Clin Microbiol Rev.
2017;31(1). pii: e00029-17). A total of 617 cases have been reported in the US
till March 29, 2019.
Last year, an elderly man died due to C. auris infection
after an abdominal surgery in Mount Sinai Hospital in New York City. The New
York Times reported, “The man at Mount Sinai died after 90 days in the
hospital, but C. auris did not. Tests showed it was everywhere in his room, so
invasive that the hospital needed special cleaning equipment and had to rip out
some of the ceiling and floor tiles to eradicate it … Everything was positive —
the walls, the bed, the doors, the curtains, the phones, the sink, the
whiteboard, the poles, the pump,” said Dr. Scott Lorin, the hospital’s
president. “The mattress, the bed rails, the canister holes, the window shades,
the ceiling, everything in the room was positive.” (New York Times, April 6,
2019)
C. auris is a deadly infection; immunocompromised
persons are more vulnerable to develop this infection. People who recently had
surgery, live in nursing homes, or who have breathing tubes, feeding tubes or
central venous catheters are especially at higher risk.
Patients can remain colonized with C. auris for
a long time and the fungus can survive on hospital surface for long
duration. This facilitates spread of C. auris between patients
in healthcare facilities.
C. auris can cause different types of infections,
including bloodstream infection, wound infection, and ear infection. The
symptoms of C. auris infection are not easily identifiable as the patients are
already critically ill.
According to the CDC, infection with C. auris is of
concern because:
· It is often
multidrug-resistant.
· It is difficult to identify
with standard laboratory methods, and it can be misidentified in labs without
specific technology, which can lead to inappropriate management.
· It has caused outbreaks in
healthcare settings. For this reason, it is important to quickly
identify C. auris in a hospitalized patient so that healthcare
facilities can take special precautions to stop its spread.
(Source: CDC)
Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of
Medical Associations in Asia and Oceania
(CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of
India
Past National President
IMA
No comments:
Post a Comment